1.1100
-0.0400
(-3.48%)
As of 2:28:04 PM EST. Market Open.
Breakdown
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Total Assets
631.5880
5,915.6250
14,516.4430
2,912.5900
Total Liabilities Net Minority Interest
3,225.7730
2,870.1220
1,164.9320
899.6430
Total Equity Gross Minority Interest
-2,594.1850
3,045.5030
13,351.5110
2,012.9470
Total Capitalization
-2,594.1850
3,045.5030
13,351.5110
2,012.9470
Preferred Stock Equity
--
--
--
0.0750
Common Stock Equity
-2,594.1850
3,045.5030
13,351.5110
2,012.8720
Net Tangible Assets
-2,594.1850
3,045.5030
13,351.5110
2,012.9470
Working Capital
-2,770.5310
2,965.6600
13,248.6020
2,012.9470
Invested Capital
-2,293.4710
3,045.5030
13,351.5110
2,348.1750
Tangible Book Value
-2,594.1850
3,045.5030
13,351.5110
2,012.8720
Total Debt
300.7140
--
--
335.3030
Share Issued
687.9990
646.2670
636.5450
566.1960
Ordinary Shares Number
687.9990
646.2670
636.5450
566.1960
4/30/2021 - 6/15/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CING Cingulate Inc.
4.5576
+0.17%
NCNA NuCana plc
1.0644
+3.30%
GRI GRI Bio, Inc.
0.6201
-5.57%
THAR Tharimmune, Inc.
1.9500
0.00%
VRAX Virax Biolabs Group Limited
1.7100
+1.18%
LGVN Longeveron Inc.
1.5450
-3.44%
XRTX XORTX Therapeutics Inc.
0.9500
+5.56%
VRPX Virpax Pharmaceuticals, Inc.
0.3041
-2.46%
BEAM Beam Therapeutics Inc.
26.22
-3.89%
IKNA Ikena Oncology, Inc.
1.4900
0.00%